Resveratrol holds promise as a novel treatment for cognitive impairment resulting from asymptomatic CASO, with its potential mechanisms primarily centered around the restoration of cerebral hemodynamic conditions, in which the NAD+/SIRT1/eNOS axis is presumed to play a pivotal role. The gene discussed is NOS3; the disease is Cognitive impairment.